Abstract
Retinoids have shown beneficial therapeutic effects in pre-clinical and animal models for multiple pathologic indications, however severe adverse effects, restricting dosage and efficacy of oral formulations limit their use in patients. The focus of this review includes the actual medicinal use of retinoids and chemical efforts to generate highly selective and less toxic synthetic retinoids.
Keywords: rar, rxr, transcription factors, cancer, skin, type II diabetes, retinoids, rexinoids
Mini-Reviews in Medicinal Chemistry
Title: Retinoids as Therapeutic Agents: Today and Tomorrow
Volume: 5 Issue: 8
Author(s): Valerie Vivat-Hannah and F. Christopher Zusi
Affiliation:
Keywords: rar, rxr, transcription factors, cancer, skin, type II diabetes, retinoids, rexinoids
Abstract: Retinoids have shown beneficial therapeutic effects in pre-clinical and animal models for multiple pathologic indications, however severe adverse effects, restricting dosage and efficacy of oral formulations limit their use in patients. The focus of this review includes the actual medicinal use of retinoids and chemical efforts to generate highly selective and less toxic synthetic retinoids.
Export Options
About this article
Cite this article as:
Vivat-Hannah Valerie and Zusi Christopher F., Retinoids as Therapeutic Agents: Today and Tomorrow, Mini-Reviews in Medicinal Chemistry 2005; 5 (8) . https://dx.doi.org/10.2174/1389557054553820
DOI https://dx.doi.org/10.2174/1389557054553820 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From ImmunoToxins to ImmunoRNases
Current Pharmaceutical Biotechnology Recent Patents on Radiotherapy Bed
Recent Patents on Mechanical Engineering ARRDC3 Inhibits the Progression of Human Prostate Cancer Through ARRDC3-ITGβ4 Pathway
Current Molecular Medicine Sirtuin Family: A Link to Metabolic Signaling and Senescence
Current Medicinal Chemistry Are Catechins, Polyphenols in Tea, Good for Your Health?
Current Nutrition & Food Science Breakthrough Pain
Current Drug Therapy Infection and Anemia
Infectious Disorders - Drug Targets Cytotoxicity of Sodium Arsenite-loaded Anti-HER2 Immunoliposomes Against HER2-expressing Human Breast Cancer Cell Lines
Letters in Drug Design & Discovery Targeted Therapies in Bone Sarcomas
Current Cancer Drug Targets Novel Drug Delivery Systems for Sustained and Targeted Delivery of Anti-Cancer Drugs: Current Status and Future Prospects
Current Drug Delivery Simple C-2-Substituted Quinolines and their Anticancer Activity
Letters in Drug Design & Discovery Homochiral Drugs: A Demanding Tendency of the Pharmaceutical Industry
Current Medicinal Chemistry Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities
Applied Clinical Research, Clinical Trials and Regulatory Affairs GSK-3 Inhibitors in the Regulation and Control of Colon Carcinoma
Current Drug Targets Rational Design and Development of Colon-Specific Prodrugs
Current Topics in Medicinal Chemistry Neuroprotective Therapies for Alzheimers Disease
Current Pharmaceutical Design Impact of Anabolic Androgenic Steroids on Neuropeptide Systems
Mini-Reviews in Medicinal Chemistry Engineered Nanoparticles in Cancer Therapy
Recent Patents on Drug Delivery & Formulation Novel 1,3,4-Triaryl Pyrazoles: Synthesis, QSAR Studies and Cytotoxicity against Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress
Current Cancer Drug Targets